Search Tag: The Institute for Cancer Research

Executive Health Management

Most-innovative-cancer-drugs-are-not-prioritised

2020 31 Jan

Innovative cancer drugs take longer to pass through clinical trials, licensing and appraisal for availability on the National Health Service ( NHS) than more conventional treatments, shows a recent study published in Drug Discovery Today .   You may also like: Cancer Research UK: Delays That Could Have Been Avoided   In...Read more